ATE48272T1 - Sulfonylharnstoffe zur tumorbekaempfung. - Google Patents

Sulfonylharnstoffe zur tumorbekaempfung.

Info

Publication number
ATE48272T1
ATE48272T1 AT86307158T AT86307158T ATE48272T1 AT E48272 T1 ATE48272 T1 AT E48272T1 AT 86307158 T AT86307158 T AT 86307158T AT 86307158 T AT86307158 T AT 86307158T AT E48272 T1 ATE48272 T1 AT E48272T1
Authority
AT
Austria
Prior art keywords
sulfonyl ureas
fighting
tumor
tumor fighting
ureas
Prior art date
Application number
AT86307158T
Other languages
English (en)
Inventor
James Jeffrey Howbert
Gerald Auston Poore
Brent Jeffrey Rieder
Richard Waltz Harper
Eddie Vi-Ping Tao
James Abraham Aikins
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Priority claimed from EP86307158A external-priority patent/EP0222475B1/de
Application granted granted Critical
Publication of ATE48272T1 publication Critical patent/ATE48272T1/de

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT86307158T 1985-09-23 1986-09-17 Sulfonylharnstoffe zur tumorbekaempfung. ATE48272T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US77935485A 1985-09-23 1985-09-23
US88867586A 1986-07-24 1986-07-24
EP86307158A EP0222475B1 (de) 1985-09-23 1986-09-17 Sulfonylharnstoffe zur Tumorbekämpfung

Publications (1)

Publication Number Publication Date
ATE48272T1 true ATE48272T1 (de) 1989-12-15

Family

ID=27229340

Family Applications (1)

Application Number Title Priority Date Filing Date
AT86307158T ATE48272T1 (de) 1985-09-23 1986-09-17 Sulfonylharnstoffe zur tumorbekaempfung.

Country Status (2)

Country Link
AT (1) ATE48272T1 (de)
MY (1) MY101025A (de)

Also Published As

Publication number Publication date
MY101025A (en) 1991-06-29

Similar Documents

Publication Publication Date Title
DE3667168D1 (de) Sulfonylharnstoffe zur tumorbekaempfung.
ATE66207T1 (de) Bicyclische sulfonamidderivate.
DE3677062D1 (de) Quelle geladener teilchen.
DE3484360D1 (de) Stabilisierte waesserige formulierungen von sulfonylharnstoffen.
FI874671A (fi) Anordning foer foerhindrande av laeckage i tryckledningar.
DE3683318D1 (de) Verwendung von alfuzosin zur behandlung von erkrankungen der harnwege.
IT8520935A0 (it) Procedimento per la sintesi di esafluorobutadiene e dieni perfluorurati superiori.
DE3667605D1 (de) Windel zur verhuetung von wundliegen.
DE3670310D1 (de) Elektrochemische behandlung von ligninen.
ES555839A0 (es) Procedimiento para la obtencion de quinoloncarboxilatos.
ES507284A0 (es) Procedimiento para la preparacion de derivados de aminoaci- dos.
MX26901A (es) Procedimiento para la reduccion directa de material.
ES2017764B3 (es) Procedimiento para el tratamiento de celulas primarias utilizadas
DE3485073D1 (de) Mittel zur bekaempfung von grundkrankheiten.
DE3689289D1 (de) Stabilisierung von Polyolefinen.
ATE25969T1 (de) 1,7-diphenyl-3-methylaza-7-cyan-8-methyl-nonan zur verwendung bei der bekaempfung von krankheiten.
FI873313A0 (fi) 2-acyloxipropylaminderivat, foerfarande foer deras framstaellning och dessa innehaollande laekemedel.
ES2002602B3 (es) Procedimiento para fabricacion de partes de conexion.
ES522213A0 (es) Procedimiento para la preparacion de derivados de quinazolina.
ATE48272T1 (de) Sulfonylharnstoffe zur tumorbekaempfung.
ATE79255T1 (de) Wirkstoffe zur verhuetung von tumormetastasen.
ES519477A0 (es) Procedimiento para la obtencion de derivados de n-(benzotiofenmetil)-n-metil-het-2-en-4-in-amina.
DE3671698D1 (de) Anordnung zur stimulation von akupunkturpunkten.
AR224302A1 (es) Procedimiento mejorado para la preparacion de cloruro de 4-triclorometoxibenzoilo
SU894881A1 (ru) Делитель частоты импульсов

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee